Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

被引：0

作者：

Pieter Jelle Visser

Lianne M. Reus

Johan Gobom

Iris Jansen

Ellen Dicks

Sven J. van der Lee

Magda Tsolaki

Frans R. J. Verhey

Julius Popp

Pablo Martinez-Lage

Rik Vandenberghe

Alberto Lleó

José Luís Molinuevo

Sebastiaan Engelborghs

Yvonne Freund-Levi

Lutz Froelich

Kristel Sleegers

Valerija Dobricic

Simon Lovestone

Johannes Streffer

Stephanie J. B. Vos

Isabelle Bos

August B. Smit

Kaj Blennow

Philip Scheltens

Charlotte E. Teunissen

Lars Bertram

Henrik Zetterberg

Betty M. Tijms

机构：

[1] Vrije Universiteit Amsterdam,Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience

[2] Maastricht University,Alzheimer Center Limburg, School for Mental Health and Neuroscience

[3] Karolinska Institutet,Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics

[4] Sahlgrenska University Hospital,Clinical Neurochemistry Laboratory

[5] Sahlgrenska Academy at the University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology

[6] VU University,Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience

[7] Vrije Universiteit Amsterdam,Section Genomics of Neurodegenerative Diseases and Aging, Department of Clinical Genetics

[8] Amsterdam UMC,1St Department of Neurology

[9] AHEPA University Hospital,Old Age Psychiatry

[10] University Hospital Lausanne,Department of Geriatric Psychiatry

[11] University Hospital of Psychiatry and University of Zürich,Laboratory for Cognitive Neurology, Department of Neurosciences

[12] Fundación CITA-Alzhéimer Fundazioa,IIB

[13] Neurology Service,Sant Pau, Hospital de La Santa Creu I Sant Pau

[14] University Hospitals Leuven,Reference Center for Biological Markers of Dementia (BIODEM), Institute Born

[15] KU Leuven,Bunge

[16] Universitat Autonoma de Barcelona,Department of Neurology, UZ Brussel and Center for Neurosciences

[17] Barcelonaβeta Brain Research Center (BBRC),Department of Psychiatry at School of Medical Sciences

[18] Alzheimer’s Disease Unit and Other Cognitive Disorders Unit,Department of Geriatric Psychiatry, Zentralinstitut Für Seelische Gesundheit

[19] Hospital Clinic de Barcelona,Department of Biomedical Sciences

[20] University of Antwerp,Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics and Cardiogenetics

[21] Vrije Universiteit Brussel,Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience

[22] Örebro University,Neurochemistry Laboratory, Department of Clinical Chemistry

[23] University of Heidelberg,Center for Lifespan Changes in Brain and Cognition, Dept. of Psychology

[24] Complex Genetics Group,Department of Neurodegenerative Disease

[25] VIB Center for Molecular Neurology,undefined

[26] VIB,undefined

[27] University of Antwerp,undefined

[28] University of Lübeck,undefined

[29] Jansen UK,undefined

[30] AC Immune SA,undefined

[31] Vrije Universiteit Amsterdam,undefined

[32] Amsterdam University Medical Centers (AUMC),undefined

[33] Amsterdam Neuroscience,undefined

[34] University of Oslo,undefined

[35] UCL Institute of Neurology,undefined

[36] Dementia Research Institute at UCL,undefined

来源：

Molecular Neurodegeneration | / 17卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease (vol 17, pg 1, 2022)
Visser, Pieter Jelle
Reus, Lianne M.
Gobom, Johan
Jansen, Iris
Dicks, Ellen
van der Lee, Sven J.
Tsolaki, Magda
Verhey, Frans R. J.
Popp, Julius
Martinez-Lage, Pablo
Vandenberghe, Rik
Lleo, Alberto
Molinuevo, Jose Luis
Engelborghs, Sebastiaan
Freund-Levi, Yvonne
Froelich, Lutz
Sleegers, Kristel
Dobricic, Valerija
Lovestone, Simon
Streffer, Johannes
Vos, Stephanie J. B.
Bos, Isabelle
Smit, August B.
Smit, August B.
Blennow, Kaj
Scheltens, Philip
Teunissen, Charlotte E.
Bertram, Lars
Zetterberg, Henrik
Tijms, Betty M.
Smit, August B.
Blennow, Kaj
Scheltens, Philip
Teunissen, Charlotte E.
Bertram, Lars
Zetterberg, Henrik
Tijms, Betty M.
MOLECULAR NEURODEGENERATION, 2022, 17 (01)
[2] Cerebrospinal fluid levels of Aβ42 and tau:: potential markers of Alzheimer's disease
Galasko, D
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (53): : 209 - 221
[3] Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease
Bekris, Lynn M.
Millard, Steve
Lutz, Franziska
Li, Gail
Galasko, Doug R.
Farlow, Martin R.
Quinn, Joseph F.
Kaye, Jeffrey A.
Leverenz, James B.
Tsuang, Debby W.
Yu, Chang-En
Peskind, Elaine R.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2012, 159B (07) : 874 - 883
[4] Increased Cerebrospinal Fluid Tau Levels in Logopenic Variant of Alzheimer's Disease
Magnin, Eloi
Paquet, Claire
Formaglio, Maite
Croisile, Bernard
Chamard, Ludivine
Miguet-Alfonsi, Carole
Tio, Gregory
Dumurgier, Julien
Roullet-Solignac, Isabelle
Sauvee, Mathilde
Thomas-Anterion, Catherine
Vighetto, Alain
Hugon, Jacques
Vandel, Pierre
JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (03) : 611 - 616
[5] Tau oligomers in cerebrospinal fluid in Alzheimer's disease
Sengupta, Urmi
Portelius, Erik
Hansson, Oskar
Farmer, Kathleen
Castillo-Carranza, Diana
Woltjer, Randall
Zetterberg, Henrik
Galasko, Douglas
Blennow, Kaj
Kayed, Rakez
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (04): : 226 - 235
[6] GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer's Disease
Cruchaga, Carlos
Kauwe, John S. K.
Harari, Oscar
Jin, Sheng Chih
Cai, Yefei
Karch, Celeste M.
Benitez, Bruno A.
Jeng, Amanda T.
Skorupa, Tara
Carrell, David
Bertelsen, Sarah
Bailey, Matthew
McKean, David
Shulman, Joshua M.
De Jager, Philip L.
Chibnik, Lori
Bennett, David A.
Arnold, Steve E.
Harold, Denise
Sims, Rebecca
Gerrish, Amy
Williams, Julie
Van Deerlin, Vivianna M.
Lee, Virginia M. -Y.
Shaw, Leslie M.
Trojanowski, John Q.
Haines, Jonathan L.
Mayeux, Richard
Pericak-Vance, Margaret A.
Farrer, Lindsay A.
Schellenberg, Gerard D.
Peskind, Elaine R.
Galasko, Douglas
Fagan, Anne M.
Holtzman, David M.
Morris, John C.
Goate, Alison M.
NEURON, 2013, 78 (02) : 256 - 268
[7] Elevated cerebrospinal fluid tau levels: Implications for the early diagnosis of Alzheimer's disease
Terajima, M
Arai, H
Itabashi, S
Higuchi, M
Zhu, CQ
Kosaka, Y
Nakagawa, T
Sasaki, H
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (08) : 1012 - 1013
[8] SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease
Cruchaga, Carlos
Kauwe, John S. K.
Mayo, Kevin
Spiegel, Noah
Bertelsen, Sarah
Nowotny, Petra
Shah, Aarti R.
Abraham, Richard
Hollingworth, Paul
Harold, Denise
Owen, Michael M.
Williams, Julie
Lovestone, Simon
Peskind, Elaine R.
Li, Ge
Leverenz, James B.
Galasko, Douglas
Morris, John C.
Fagan, Anne M.
Holtzman, David M.
Goate, Alison M.
PLOS GENETICS, 2010, 6 (09)
[9] Abnormal tau proteins and neuronal degeneration in Alzheimer's disease
Bondareff, W
Matsuyama, SS
INTERNATIONAL REVIEW OF PSYCHIATRY, 1995, 7 (3-4) : 349 - 360
[10] Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease
Bos, Isabelle
Vos, Stephanie J. B.
Schindler, Suzanne E.
Hassenstab, Jason
Xiong, Chengjie
Grant, Elizabeth
Verhey, Frans
Morris, John C.
Visser, Pieter Jelle
Fagan, Anne M.
ALZHEIMERS & DEMENTIA, 2019, 15 (09) : 1149 - 1159

← 1 2 3 4 5 →